Participants 41 84 5
patients with mild obstructive sleep apnea.
Participants 154 210 3
cardiovascular diseases in obstructive sleep apnea (OSA)
Participants 546 579 5
overweight patients with mild OSA
Participants 601 877 5
Patients were randomized to supervised intensive lifestyle intervention group (N=28) or to control group (N=31), which received routine lifestyle advices. Circulating concentrations of pro- and anti-inflammatory mediators were measured before and after the 1-year intervention
Participants 1578 1612 3
overweight patients with mild OSA,
